Ignite Creation Date:
2024-05-06 @ 2:29 AM
Last Modification Date:
2024-10-26 @ 11:19 AM
Study NCT ID:
NCT02053636
Status:
COMPLETED
Last Update Posted:
2020-01-03
First Post:
2014-01-24
Brief Title:
A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor FGFR1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer
Sponsor:
Institut de Recherches Internationales Servier
Organization:
Servier
Organization Data
Organization:
Servier
Class:
INDUSTRY
Study ID:
CL2-80881-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institut de Recherches Internationales Servier
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Breast International Group | OTHER |